Cholinergic Antagonists
Showing 1 - 25 of 821
Deprescriptions, Antidepressive Agents, Antipsychotic Agents Trial in Bielefeld, Munich, Witten (PARTNER intervention, Control
Recruiting
- Deprescriptions
- +5 more
- PARTNER intervention
- Control intervention
-
Bielefeld, Germany
- +2 more
Apr 24, 2023
Hyperhidrosis, Oxybutynin, Sweat Gland Diseases Trial in São Paulo (Topical oxybutynin spray, Topical spray, Oral oxybutynin)
Not yet recruiting
- Hyperhidrosis
- +6 more
- Topical oxybutynin spray
- +2 more
-
São Paulo, SP, BrazilIrmandade da Santa Casa de Misericórdia de São Paulo
Oct 27, 2021
During Hyperventilation in Normal Individuals and in Mild and
Recruiting
- Hyperventilation
- +2 more
- Acute Hyperventilation
- +2 more
-
Clayton, Victoria, AustraliaMonash Medical Centre
Oct 3, 2022
Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)
Recruiting
- Postmenopausal Symptoms
- +2 more
- Cholinergic antagonist
-
Nashville, Tennessee
- +1 more
Mar 23, 2022
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Deprescribing Anticholinergic and Sedative Medications, Physical Function Trial (Deprescribing anticholinergic and sedative
Not yet recruiting
- Deprescribing Anticholinergic and Sedative Medications
- Physical Function
- Deprescribing anticholinergic and sedative mediications
- (no location specified)
Feb 9, 2023
Reversibility of Bronchial Obstruction in Children Born Preterm
Recruiting
- Bronchopulmonary Dysplasia
- +6 more
-
Prague, CzechiaFirst faculty of Medicine, Charles university.
Oct 29, 2023
Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease
Completed
- Pulmonary Disease, Chronic Obstructive
- Tiotropium+Olodaterol
- +3 more
-
Taiwan, ChinaHealth Data Research Center, National Taiwan University
Jan 3, 2023
Anticholinergic Burden With Onset of Delirium in Older Alzheimer
Recruiting
- Delirium
- +2 more
- Anticholinergic burden
-
Ankara, TurkeyGulhane training and research hospital
Sep 15, 2021
Penehyclidine, Postoperative Nausea and Vomiting, Bimaxillar Surgery Trial in Beijing (Single injection of penehyclidine,
Completed
- Penehyclidine
- +2 more
- Single injection of penehyclidine
- +2 more
-
Beijing, ChinaPeking Univeristy Hospital Stomatology
Sep 14, 2021
Voiding Disorders, Overactive Bladder Trial (Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin)
Not yet recruiting
- Voiding Disorders
- Overactive Bladder
- Beta3-Agonists, Adrenergic
- Anticholinergic drug, Solifenacin
- (no location specified)
Feb 13, 2022
COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)
Recruiting
- COPD Exacerbation
- Long acting muscarinic antagonists (LAMAs) at bedtime
-
Copenhagen, DenmarkHerlev-Gentofte Hospital
Jan 30, 2023
Bladder Dysfunction, Multiple Sclerosis Trial in Worldwide (CIC using LoFric Primo, Anticholinergic medication)
Terminated
- Bladder Dysfunction
- Multiple Sclerosis
- CIC using LoFric Primo
- Anticholinergic medication
-
Esneux, Belgium
- +4 more
Nov 10, 2021
Mood Disorders, Healthy, Unipolar Depression Trial run by the NIMH (Scopolamine Nasal Spray)
Terminated
- Mood Disorders
- +3 more
- Scopolamine Nasal Spray
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 17, 2021
Cholinergic Integrity in Down Syndrome in Association With
Recruiting
- Down Syndrome
- +2 more
- [18F]-FEOBV Radiotracer
-
Nashville, TennesseeVanderbilt University Medical Center Clinical Research Center
Jan 31, 2023
Patients Suffered Substance Abuse Related Voiding Dysfunction
Recruiting
- Voiding Dysfunction
- Substance Abuse
- First line treatment: oral NSAID and anticholinergic agents
- +3 more
-
Shatin, Hong KongPrince of Wales Hospital
Mar 9, 2022
Nicotine Dependence Trial in Belmont (Suvorexant 20 mg, Suvorexant 10 mg, Placebo oral tablet)
Recruiting
- Nicotine Dependence
- Suvorexant 20 mg
- +2 more
-
Belmont, MassachusettsMcLean Hospital
Aug 30, 2021
Dementia, Alzheimer, Late Onset Trial in Indianapolis (Deprescribing of target anticholinergics, Usual Care)
Recruiting
- Dementia
- Alzheimer Disease, Late Onset
- Deprescribing of target anticholinergics
- Usual Care
-
Indianapolis, Indiana
- +1 more
Feb 23, 2022
Alzheimer Trial in Mineola (Donepezil Hydrochloride, Placebo)
Completed
- Alzheimer Disease
- Donepezil Hydrochloride
- Placebo
-
Mineola, New YorkWinthrop-University Hospital
Jan 13, 2021
Inflammation Trial in Las Cruces (Occipito-Atlantal Decompression (OA DC), Sham Occipito-Atlantal Decompression (Sham OA DC),
Recruiting
- Inflammation
- Occipito-Atlantal Decompression (OA DC)
- +5 more
-
Las Cruces, New MexicoBurrell College of Osteopathic Medicine
Jan 28, 2022
Cold Urticaria, Cold Contact Urticaria, Symptomatic Dermographism Trial in Berlin (CDX-0159)
Active, not recruiting
- Cold Urticaria
- +4 more
-
Berlin, GermanyCharite University
Dec 20, 2022
Visualising Cerebral and Peripheral Cholinergic Nerves in
Recruiting
- Dementia With Lewy Bodies
- +3 more
- PET-CT using FEOBV
- +3 more
-
Aarhus N, DenmarkDepartment of Nuclear medicine and PET, Aarhus University Hospit
May 19, 2022
Perennial Allergic Rhinitis Trial (Desloratadine 5 mg, Placebo)
Completed
- Perennial Allergic Rhinitis
- Desloratadine 5 mg
- Placebo
- (no location specified)
Feb 7, 2022
Cholinergic Urticaria Trial in Germany (LEO 152020, LEO 152020 )
Completed
- Cholinergic Urticaria
- LEO 152020
- LEO 152020 placebo
-
Aachen, Germany
- +5 more
Sep 1, 2022
HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive
Recruiting
- Drug Monitoring
- Inflammatory Bowel Diseases
- Tumor necrosis factor (TNF)-alpha inhibitors
-
Valladolid, SpainHospital Universitario Rio Hortega
Aug 8, 2023